Hello and Welcome to Patientsville.com, Your Source for all BEZAFIBRATE information. We are dedicated to provide You with BEZAFIBRATE safety information. Learn about BEZAFIBRATE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
BEZAFIBRATE Safety Reports
Total BEZAFIBRATE reports: 3.BEZAFIBRATE FDA safety alerts: No.
.
Take BEZAFIBRATE Side Effects Survey or Share Your BEZAFIBRATE Story. Read More Here.
Health Professional from UNITED KINGDOM reported BEZAFIBRATE problem on Mar 07, 2007. Male patient, 39 years of age, was diagnosed with hypercholesterolaemia and was treated with BEZAFIBRATE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dizziness, psoriasis. BEZAFIBRATE dosage: 200 MG, QD. During the same period patient was treated with SIMVASTATIN. Patient recovered.
BEZAFIBRATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 04, 2006. Male patient, 39 years of age, was diagnosed with hypercholesterolaemia and was treated with BEZAFIBRATE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dizziness, pustular psoriasis. BEZAFIBRATE dosage: 200 MG, QD. During the same period patient was treated with PRAVASTATIN, SIMVASTATIN. Patient recovered.
Health Professional from UNITED KINGDOM reported BEZAFIBRATE problem on Dec 04, 2006. Male patient, 39 years of age, was diagnosed with hypercholesterolaemia and was treated with BEZAFIBRATE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dizziness, psoriasis. BEZAFIBRATE dosage: 200 MG, QD,. During the same period patient was treated with PRAVASTATIN, SIMVASTATIN. Patient recovered.